Binovi Technologies Corp. (TSX-V:VISN, OTCQB:BNVIF) said it has appointed Jatinder Dhaliwal as its chief executive officer and to the company's board of directors.
A registered pharmacist, Dhaliwal is the director of multiple publicly traded companies and has extensive knowledge in agricultural, medical and pharmaceutical operations, Binovi said.
“With Mr. Dhaliwal's appointment, Binovi will enhance its access to capital markets and health care industry networks, which will be valuable assets towards the execution on Binovi's strategy and conversion of business prospects,“ said Terry Booth, chairman of the board in a statement.
Dhaliwal holds bachelor's degrees in pharmacy and biology from the University of British Columbia and University of Victoria respectively. He has overseen the acquisition and development of numerous projects, technology platforms and applications, added Binovi.
The company also said that Marc Lakmaaker, its interim CEO, has resigned and is no longer a director of the company with immediate effect.
“I would like to thank Marc for taking on the role as interim CEO, in which capacity he successfully led crucial clean-up efforts and spearheaded important initiatives that we believe will create significant value for the company going forward," added Booth.
Binovi is a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance. It combines hardware, software, specialized expert knowledge, and unique data insights to deliver customized, one-on-one training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training.